BV Financial (BVFL) lifts Q2 2026 earnings as loans shrink, cash rises

BV Financial (BVFL) reported Q2 2026 net income of $3.46M, up from $2.86M a year earlier, with basic EPS rising to $0.43 from $0.29. As of June 30, 2026, total assets were $878M, loans $711M, cash and cash equivalents $68.9M, and FHLB borrowings fell to zero. Non-accrual loans increased to $3.41M from $2.26M.

Original reporting
Published Aug 12, 2026, 3:22 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 13, 2026, 1:57 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$BVFL
Neutral
medium confidence
Mentioned
$BVFL
Relevance
7/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$BVFLNeutralMed
01

Why it matters

Net interest income and net income increased year over year, while loans declined and cash increased. Credit quality deteriorated as non-accrual loans rose, and the allowance for credit losses is reported at $6.21M.

02

Market read

Traders may reprice the stock based on the combination of improved profitability metrics and worsening credit-quality indicators in the same quarter.

03

What to watch

Non-accruals rose to $3.41M from $2.26M, but the article does not quantify charge-offs, delinquency roll rates, or forward guidance, which are crucial for assessing whether credit pressure is transient or worsening.

Relevance 7/10Novelty 6/10Timing: reported Q2 2026 results in a 10-Q dated for the quarter ended June 30, 2026

Background

The article summarizes BV Financial’s quarterly update (Form 10-Q) with balance-sheet and income statement highlights for the quarter ended June 30, 2026.

Company-level read

Ticker impact

$BVFLNeutralMedium confidence
Context

BV Financial reported Q2 2026 net income of $3.46M and EPS of $0.43, alongside shrinking loans and higher cash.

Expected impact

Near-term bias mixed: support from higher earnings, offset by rising non-accruals and credit-loss allowance context.

Evidence & confidence

The article provides directionally positive income metrics (net income, EPS) and balance-sheet shifts (loans down, cash up), while also flagging a deterioration in non-accrual loans versus Dec 31, 2025.

Market effects

Small-bank read-through: improving profitability can coexist with rising non-accruals, keeping credit risk a key valuation driver.

No specific regional or geographic impact is disclosed beyond the bank’s balance-sheet movements.

Limited global relevance; this is company-specific small-bank financial performance and credit metrics.

Counterpoint

The earnings improvement may be partly mechanical from balance-sheet repositioning (loans down, cash up) rather than sustainable credit normalization.

Key entities

  • BV Financial, Inc.

    Reported Q2 2026 earnings and balance-sheet changes, including shrinking loans, higher cash, and rising non-accrual loans.

  • Federal Home Loan Bank borrowings

    Borrowings were reduced from $35M to zero as of June 30, 2026.

Related articles

$BVFLLow

BV FINANCIAL, INC. ANNOUNCES FINANCIAL RESULTS

BV Financial, Inc. (BVFL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Contact: Michael J. Dee Chief Financial Officer (410) 477- 5000 BV FINANCIAL, INC. ANNOUNCES FINANCIAL RESULTS Baltimore, Maryland, October 23, 2026– BV Financial, Inc. (NASDAQ: BVFL), the holding company for BayVanguard Bank (the “Bank”), today reported net income o

$BVFLMed

BV FINANCIAL, INC. ANNOUNCES FINANCIAL RESULTS

BV Financial, Inc. (BVFL) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 bvfl-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Contact: Michael J. Dee Chief Financial Officer (410) 477- 5000 BV FINANCIAL, INC. ANNOUNCES FINANCIAL RESULTS Baltimore, Maryland, July 24, 2026– BV Financial, Inc. (NASDAQ: BVFL), the holding company for BayVanguard Bank (t

$NMAXMed

Why Newsmax Stock Popped on Friday

Newsmax (NMAX) shares rose 31% after reporting Q3 revenue of $69M, up 52.5% YoY, and net income of $15.2M. The company cited strong audience engagement and growth in high-margin revenue streams. CEO Christopher Ruddy expects continued growth ahead of the presidential election.

$LUNRMed

What Is Driving Intuitive Machines Stock?

Intuitive Machines (LUNR) shares rose 7.0% on Nov 12, 2026, after reporting Q3 revenue of $269M, beating estimates. The company's loss of $0.10 per share met expectations, while gross margin improved to 26%. Free cash flow turned positive at $33M, a company record. Management raised full-year revenue guidance to $920M-$950M. The stock's performance contrasted with broader industry declines.

$RMIXMedAI 8/10

Suncrete (RMIX) Q3 2026 Earnings Call Transcript

Suncrete (RMIX) reported Q3 2026 revenue of $141M, up 45% QoQ and 163% YoY. Adjusted EBITDA rose 66% QoQ to $22.4M. The company lowered its full-year outlook due to residential construction weakness but remains confident in long-term demand. Acquisition integration is progressing, with North Texas showing margin improvement. Suncrete expects $200M-$250M revenue from 2026 acquisitions in 2027. The company has $206.5M in total liquidity.

$CLLSMed

Cellectis SA (CLLS) (Q3 2026) Earnings Call Highlights: Strategic Shift to Gene

Cellectis SA (CLLS) discussed its strategic shift to gene editing during its Q3 2026 earnings call. Management highlighted the selection of APOC3 over ANGPTL3 for triglyceride reduction, with plans to start Phase 1 dosing by end-2027. The company reported $149M in cash as of September 30, 2026, with a runway into H2 2028. Revenue decreased to $19.9M from $67.4M YoY, while R&D expenses increased to $108.8M from $69.1M, driven by the AstraZeneca collaboration.